2 unknown, 1 completed. 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Lotus Pharmaceutical: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus Acarbose, Metformin/Acarbose - The Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg, Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in | Phase 3 | Unknown | Lotus Pharmaceutical | 220 | 2010-11-01 | 2010-11-22 |
| The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria Denosin® and Xyzal® - Chronic Idiopathic Urticaria, Urticaria | Phase 4 | Unknown | Lotus Pharmaceutical | 60 | 2006-01-01 | 2006-06-30 |
| Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine Laxymig ER (drug) - Migraine With Aura, Migraine Without Aura | Phase 3 | Completed | Lotus Pharmaceutical | 74 | 2004-11-01 | 2007-09-10 |
Chronic Urticaria (1) · Migraine Disorders (1) · Migraine with Aura (1) · Migraine without Aura (1) · Urticaria (1)
Acarbose (1) · Metformin (1) · Pharmaceutical Preparations (1) · levocetirizine (1)
Taiwan (3)
Jia-Yu Chu (1) · Shuu-Jiun Wang, MD (1)